267 related articles for article (PubMed ID: 16251389)
1. Immune-related conditions and immune-modulating medications as risk factors for non-Hodgkin's lymphoma: a case-control study.
Engels EA; Cerhan JR; Linet MS; Cozen W; Colt JS; Davis S; Gridley G; Severson RK; Hartge P
Am J Epidemiol; 2005 Dec; 162(12):1153-61. PubMed ID: 16251389
[TBL] [Abstract][Full Text] [Related]
2. Autoimmune and chronic inflammatory disorders and risk of non-Hodgkin lymphoma by subtype.
Smedby KE; Hjalgrim H; Askling J; Chang ET; Gregersen H; Porwit-MacDonald A; Sundström C; Akerman M; Melbye M; Glimelius B; Adami HO
J Natl Cancer Inst; 2006 Jan; 98(1):51-60. PubMed ID: 16391371
[TBL] [Abstract][Full Text] [Related]
3. Anthropometrics, physical activity, related medical conditions, and the risk of non-hodgkin lymphoma.
Cerhan JR; Bernstein L; Severson RK; Davis S; Colt JS; Blair A; Hartge P
Cancer Causes Control; 2005 Dec; 16(10):1203-14. PubMed ID: 16215871
[TBL] [Abstract][Full Text] [Related]
4. Non-Hodgkin's lymphoma associated with primary Sjögren's syndrome.
Pariente D; Anaya JM; Combe B; Jorgensen C; Emberger JM; Rossi JF; Sany J
Eur J Med; 1992 Oct; 1(6):337-42. PubMed ID: 1341461
[TBL] [Abstract][Full Text] [Related]
5. Altered immunity as a risk factor for non-Hodgkin lymphoma.
Grulich AE; Vajdic CM; Cozen W
Cancer Epidemiol Biomarkers Prev; 2007 Mar; 16(3):405-8. PubMed ID: 17337643
[TBL] [Abstract][Full Text] [Related]
6. The risk of lymphoma development in autoimmune diseases: a meta-analysis.
Zintzaras E; Voulgarelis M; Moutsopoulos HM
Arch Intern Med; 2005 Nov; 165(20):2337-44. PubMed ID: 16287762
[TBL] [Abstract][Full Text] [Related]
7. Occupational risk factors for non-Hodgkin's lymphoma: a population-based case-control study in Northern Germany.
Richardson DB; Terschüren C; Hoffmann W
Am J Ind Med; 2008 Apr; 51(4):258-68. PubMed ID: 18213641
[TBL] [Abstract][Full Text] [Related]
8. Birth order, atopy, and risk of non-Hodgkin lymphoma.
Grulich AE; Vajdic CM; Kaldor JM; Hughes AM; Kricker A; Fritschi L; Turner JJ; Milliken S; Benke G; Armstrong BK
J Natl Cancer Inst; 2005 Apr; 97(8):587-94. PubMed ID: 15840881
[TBL] [Abstract][Full Text] [Related]
9. Sjögren's syndrome in patients with newly diagnosed untreated non-Hodgkin's lymphoma.
Andonopoulos AP; Tiniakou M; Melachrinou M; Sfountouris H; Bounas A; Zervas C; Zoumbos NC
Rev Rhum Engl Ed; 1997 May; 64(5):287-92. PubMed ID: 9190001
[TBL] [Abstract][Full Text] [Related]
10. Risk of non-Hodgkin's lymphoma and family history of lymphatic, hematologic, and other cancers.
Chatterjee N; Hartge P; Cerhan JR; Cozen W; Davis S; Ishibe N; Colt J; Goldin L; Severson RK
Cancer Epidemiol Biomarkers Prev; 2004 Sep; 13(9):1415-21. PubMed ID: 15342441
[TBL] [Abstract][Full Text] [Related]
11. The effect of atopy, childhood crowding, and other immune-related factors on non-Hodgkin lymphoma risk.
Cozen W; Cerhan JR; Martinez-Maza O; Ward MH; Linet M; Colt JS; Davis S; Severson RK; Hartge P; Bernstein L
Cancer Causes Control; 2007 Oct; 18(8):821-31. PubMed ID: 17588155
[TBL] [Abstract][Full Text] [Related]
12. Medication use and risk of non-Hodgkin's lymphoma.
Chang ET; Smedby KE; Hjalgrim H; Schöllkopf C; Porwit-MacDonald A; Sundström C; Tani E; d'Amore F; Melbye M; Adami HO; Glimelius B
Am J Epidemiol; 2005 Nov; 162(10):965-74. PubMed ID: 16192343
[TBL] [Abstract][Full Text] [Related]
13. The epidemiology of non-Hodgkin lymphoma.
Grulich AE; Vajdic CM
Pathology; 2005 Dec; 37(6):409-19. PubMed ID: 16373224
[TBL] [Abstract][Full Text] [Related]
14. Malignant lymphoma-associated autoimmune diseases--a descriptive epidemiological study.
Váróczy L; Gergely L; Zeher M; Szegedi G; Illés A
Rheumatol Int; 2002 Nov; 22(6):233-7. PubMed ID: 12426661
[TBL] [Abstract][Full Text] [Related]
15. Autoimmune disease is a risk factor for the development of non-Hodgkin's lymphoma.
Cuttner J; Spiera H; Troy K; Wallenstein S
J Rheumatol; 2005 Oct; 32(10):1884-7. PubMed ID: 16206341
[TBL] [Abstract][Full Text] [Related]
16. Differential risk of non-Hodgkin's lymphoma in Italian patients with primary Sjögren's syndrome.
Valesini G; Priori R; Bavoillot D; Osborn J; Danieli MG; Del Papa N; Gerli R; Pietrogrande M; Sabbadini MG; Silvestris F; Valsecchi L
J Rheumatol; 1997 Dec; 24(12):2376-80. PubMed ID: 9415645
[TBL] [Abstract][Full Text] [Related]
17. High risk occupations for non-Hodgkin's lymphoma in New Zealand: case-control study.
't Mannetje A; Dryson E; Walls C; McLean D; McKenzie F; Maule M; Cheng S; Cunningham C; Kromhout H; Boffetta P; Blair A; Pearce N
Occup Environ Med; 2008 May; 65(5):354-63. PubMed ID: 18032530
[TBL] [Abstract][Full Text] [Related]
18. Non-Hodgkin's lymphoma--meta-analyses of the effects of corticosteroids and non-steroidal anti-inflammatories.
Bernatsky S; Lee JL; Rahme E
Rheumatology (Oxford); 2007 Apr; 46(4):690-4. PubMed ID: 17148471
[TBL] [Abstract][Full Text] [Related]
19. Obesity and risk of non-Hodgkin lymphoma (United States).
Chiu BC; Soni L; Gapstur SM; Fought AJ; Evens AM; Weisenburger DD
Cancer Causes Control; 2007 Aug; 18(6):677-85. PubMed ID: 17484069
[TBL] [Abstract][Full Text] [Related]
20. Personal and occupational exposure to organic solvents and risk of non-Hodgkin's lymphoma (NHL) in women (United States).
Kato I; Koenig KL; Watanabe-Meserve H; Baptiste MS; Lillquist PP; Frizzera G; Burke JS; Moseson M; Shore RE
Cancer Causes Control; 2005 Dec; 16(10):1215-24. PubMed ID: 16215872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
